Furthermore, to confirm the effect of NORAD on ESCC cells, we constructed shRNAs to knock down NORAD expression in CDDP-resistant ESCC cells, and plasmids to overexpress NORAD in parental ESCC cells (Additional file 2: Fig. S3a-b). The gene discussed is NORAD; the disease is esophageal squamous cell carcinoma.